BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 25223755)

  • 1. Patterns of structural variants within TP53 introns and relocation of the TP53 promoter: a commentary
    Beird HC; Lin D; Lazar AJ; Futreal PA
    J Pathol; 2024 Jun; 263(2):131-134. PubMed ID: 38482738
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Saif R; Awan AR; Lyons L; Gandolfi B; Tayyab M; Ellahi Babar M; Khalid Mehmood A; Ullah Z; Wasim M
    Iran J Biotechnol; 2016 Sep; 14(3):202-212. PubMed ID: 28959337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SOX2 and SOX2-MYC Reprogramming Process of Fibroblasts to the Neural Stem Cells Compromised by Senescence.
    Winiecka-Klimek M; Smolarz M; Walczak MP; Zieba J; Hulas-Bigoszewska K; Kmieciak B; Piaskowski S; Rieske P; Grzela DP; Stoczynska-Fidelus E
    PLoS One; 2015; 10(11):e0141688. PubMed ID: 26535892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma.
    Ding SL; Yang ZW; Wang J; Zhang XL; Chen XM; Lu FM
    World J Gastroenterol; 2015 May; 21(20):6317-28. PubMed ID: 26034368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatic TP53 Mutations in the Era of Genome Sequencing.
    Hainaut P; Pfeifer GP
    Cold Spring Harb Perspect Med; 2016 Nov; 6(11):. PubMed ID: 27503997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PIN3 duplication may be partially responsible for TP53 haploinsufficiency.
    Winiecka-Klimek M; Szybka M; Rieske P; Piaskowski S; Bienkowski M; Walczak M; Pacholczyk M; Rostkowski M; Zieba J; Banaszczyk M; Hulas-Bigoszewska K; Peciak J; Pawliczak R; Stoczynska-Fidelus E
    BMC Cancer; 2014 Sep; 14():669. PubMed ID: 25223755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of TP53 intron 3, 16 bp duplication polymorphism with esophageal and gastric cancer susceptibility in Kashmir Valley.
    Malik MA; Sharma K; Goel S; Zargar SA; Mittal B
    Oncol Res; 2011; 19(3-4):165-9. PubMed ID: 21473292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of PIN3 16-bp duplication polymorphism of TP53 with breast cancer risk in Mali and a meta-analysis.
    Diakite B; Kassogue Y; Dolo G; Kassogue O; Keita ML; Joyce B; Neuschler E; Wang J; Musa J; Traore CB; Kamate B; Dembele E; Nadifi S; Isichei M; Holl JL; Murphy R; Doumbia S; Hou L; Maiga M
    BMC Med Genet; 2020 Jul; 21(1):142. PubMed ID: 32620097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TP53 and p21 (CDKN1A) polymorphisms and the risk of systemic lupus erythematosus.
    Macedo JMB; Silva AL; Pinto AC; Landeira LFL; Portari EA; Santos-Rebouças CB; Klumb EM
    Adv Rheumatol; 2023 Aug; 63(1):43. PubMed ID: 37605254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TP53 PIN3 and MDM2 SNP309 polymorphisms as genetic modifiers in the Li-Fraumeni syndrome: impact on age at first diagnosis.
    Marcel V; Palmero EI; Falagan-Lotsch P; Martel-Planche G; Ashton-Prolla P; Olivier M; Brentani RR; Hainaut P; Achatz MI
    J Med Genet; 2009 Nov; 46(11):766-72. PubMed ID: 19542078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of TP53 PIN3 polymorphism with breast cancer in Moroccan population.
    Marouf C; Tazzite A; Diakité B; Jouhadi H; Benider A; Nadifi S
    Tumour Biol; 2014 Dec; 35(12):12403-8. PubMed ID: 25201062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for EGFR amplifications with a novel method and their significance for the outcome of glioblastoma patients.
    Bieńkowski M; Piaskowski S; Stoczyńska-Fidelus E; Szybka M; Banaszczyk M; Witusik-Perkowska M; Jesień-Lewandowicz E; Jaskólski DJ; Radomiak-Załuska A; Jesionek-Kupnicka D; Sikorska B; Papierz W; Rieske P; Liberski PP
    PLoS One; 2013; 8(6):e65444. PubMed ID: 23762372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-transcriptional formation of DNA:RNA hybrid G-quadruplex and potential function as constitutional cis element for transcription control.
    Zheng KW; Xiao S; Liu JQ; Zhang JY; Hao YH; Tan Z
    Nucleic Acids Res; 2013 May; 41(10):5533-41. PubMed ID: 23585281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A meta-analysis of cancer risk associated with the TP53 intron 3 duplication polymorphism (rs17878362): geographic and tumor-specific effects.
    Sagne C; Marcel V; Amadou A; Hainaut P; Olivier M; Hall J
    Cell Death Dis; 2013 Feb; 4(2):e492. PubMed ID: 23412385
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.